COVID-19 Vaccination among HIV+ Patients: An Italian Cross-Sectional Survey

Author:

Bert Fabrizio,Pivi AlexORCID,Russotto AntoninoORCID,Mollero Benedetta,Voglino Gianluca,Orofino Giancarlo,Siliquini Roberta

Abstract

Background: This study aims to evaluate knowledge, attitudes and practices (KAP) of HIV-patients about COVID-19 vaccination. Methods: A cross-sectional study was conducted by administering questionnaires to 160 patients followed by Amedeo di Savoia Hospital in Turin. Statistical analyses were performed in order to identify predictors of infection and severity of COVID-19 disease risk perception. Results: The 86.2% of patients were vaccinated for COVID-19, while 7.6% do not intend to be vaccinated; 50.7% thought that there is a minimal risk to get COVID-19; 85.8% thought that COVID-19 is a serious illness. The 56% and the 36.5 thought that seropositivity carries a greater risk to develop respectively COVID-19-related complications or vaccine complications. At the multivariate analysis having a job, proactive research of vaccine information and being HIV+ for several years are related to a lower risk perception of infection. The perception of COVID-19 severity is influenced by age, by being LGB and by believing that HIV+ status correlates with a higher risk of developing complications from COVID-19. Conclusions: as the pandemic can adversely impact the HIV care with increasing loss to follow-up, vaccination is essential to contrast infection in HIV+ patients. Our findings suggested that some HIV+ patients refuse vaccination against COVID-19.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference43 articles.

1. Opening Remarks at the Media Briefing on COVID-19 https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---16-march-2020

2. WHO Coronavirus (COVID-19) Dashboard https://covid19.who.int

3. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19

4. Status of COVID-19 Vaccines within WHO EUL/PQ Evaluation Process Assessment. Status of COVID-19 Vaccines within WHO EUL/PQ Evaluation Process https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_07July2022.pdf

5. EMA Recommends First COVID-19 Vaccine for Authorisation in the EU https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3